FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002152406> ?p ?o ?g. }

• W2002152406 endingPage "718" @default.
• W2002152406 startingPage "704" @default.
• W2002152406 abstract "Purpose Low docosahexaenoic acid (DHA) in X-linked retinitis pigmentosa (XLRP) may influence retinal function. The goals of this study were to elevate blood DHA levels and determine the effect on the rate of disease progression. Design In a 4-year prospective randomized clinical trial, male patients with XLRP (mean age = 16 years; range = 4–38 years) received DHA (400 mg/d; n = 23; +DHA group) or placebo (n = 21) capsules. Methods Red blood cell (RBC)-DHA concentrations were assessed every 6 months. Full-field cone electroretinograms (ERGs; the primary outcome measure), visual acuity, dark-adaptation, visual fields, rod ERGs, and fundus photos were recorded annually. Results In the +DHA group, RBC-DHA increased 2.5-fold over placebo levels (70 vs 28 mg DHA/l). Repeated measures analysis of variance for cone ERG showed a significant main effect of year (P < .0001) but not of group (P = .16). Preservation of cone ERG function correlated with RBC-DHA (P = .018), and there was less change in fundus appearance in the +DHA group (P = .04). Neither visual acuity nor visual fields were changed. In subset analysis, DHA supplementation was beneficial in reducing rod ERG functional loss in patients aged <12 years (P = .040) and preserving cone ERG function in patients ≥12 years (P = .038). Conclusions Although DHA-supplemented patients had significantly elevated mean RBC-DHA levels, the rate of cone ERG functional loss was not significantly different between groups. Supplemental analyses provided evidence for a DHA benefit and a direction for subsequent investigations." @default.
• W2002152406 created "2016-06-24" @default.
• W2002152406 creator A5002663254 @default.
• W2002152406 creator A5018933449 @default.
• W2002152406 creator A5033773222 @default.
• W2002152406 creator A5042668833 @default.
• W2002152406 creator A5051602947 @default.
• W2002152406 creator A5058220212 @default.
• W2002152406 date "2004-04-01" @default.
• W2002152406 modified "2023-10-10" @default.
• W2002152406 title "A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa" @default.
• W2002152406 cites W1565206912 @default.
• W2002152406 cites W1571786712 @default.
• W2002152406 cites W1573169726 @default.
• W2002152406 cites W1868418158 @default.
• W2002152406 cites W1967380123 @default.
• W2002152406 cites W1971234951 @default.
• W2002152406 cites W1972323290 @default.
• W2002152406 cites W1980056828 @default.
• W2002152406 cites W1980965086 @default.
• W2002152406 cites W1989939875 @default.
• W2002152406 cites W1991817461 @default.
• W2002152406 cites W1997160062 @default.
• W2002152406 cites W2008396993 @default.
• W2002152406 cites W2010775690 @default.
• W2002152406 cites W2013238661 @default.
• W2002152406 cites W2013303896 @default.
• W2002152406 cites W2014637055 @default.
• W2002152406 cites W2018918067 @default.
• W2002152406 cites W2031731414 @default.
• W2002152406 cites W2040541933 @default.
• W2002152406 cites W2043011906 @default.
• W2002152406 cites W2045744645 @default.
• W2002152406 cites W2048140541 @default.
• W2002152406 cites W2048505879 @default.
• W2002152406 cites W2051565465 @default.
• W2002152406 cites W2053102875 @default.
• W2002152406 cites W2054328432 @default.
• W2002152406 cites W2076082580 @default.
• W2002152406 cites W2080622533 @default.
• W2002152406 cites W2090912192 @default.
• W2002152406 cites W2139575725 @default.
• W2002152406 cites W2161723666 @default.
• W2002152406 cites W2167846045 @default.
• W2002152406 cites W2168442692 @default.
• W2002152406 cites W2341967996 @default.
• W2002152406 cites W2416309522 @default.
• W2002152406 cites W307875123 @default.
• W2002152406 cites W4249024179 @default.
• W2002152406 cites W4376043502 @default.
• W2002152406 doi "https://doi.org/10.1016/j.ajo.2003.10.045" @default.
• W2002152406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15059710" @default.
• W2002152406 hasPublicationYear "2004" @default.
• W2002152406 type Work @default.
• W2002152406 sameAs 2002152406 @default.
• W2002152406 citedByCount "65" @default.
• W2002152406 countsByYear W20021524062012 @default.
• W2002152406 countsByYear W20021524062013 @default.
• W2002152406 countsByYear W20021524062014 @default.
• W2002152406 countsByYear W20021524062015 @default.
• W2002152406 countsByYear W20021524062016 @default.
• W2002152406 countsByYear W20021524062017 @default.
• W2002152406 countsByYear W20021524062018 @default.
• W2002152406 countsByYear W20021524062019 @default.
• W2002152406 countsByYear W20021524062020 @default.
• W2002152406 countsByYear W20021524062021 @default.
• W2002152406 countsByYear W20021524062022 @default.
• W2002152406 crossrefType "journal-article" @default.
• W2002152406 hasAuthorship W2002152406A5002663254 @default.
• W2002152406 hasAuthorship W2002152406A5018933449 @default.
• W2002152406 hasAuthorship W2002152406A5033773222 @default.
• W2002152406 hasAuthorship W2002152406A5042668833 @default.
• W2002152406 hasAuthorship W2002152406A5051602947 @default.
• W2002152406 hasAuthorship W2002152406A5058220212 @default.
• W2002152406 hasConcept C103796816 @default.
• W2002152406 hasConcept C118487528 @default.
• W2002152406 hasConcept C126322002 @default.
• W2002152406 hasConcept C142724271 @default.
• W2002152406 hasConcept C19038510 @default.
• W2002152406 hasConcept C204787440 @default.
• W2002152406 hasConcept C27081682 @default.
• W2002152406 hasConcept C2776391266 @default.
• W2002152406 hasConcept C2777171753 @default.
• W2002152406 hasConcept C2778257484 @default.
• W2002152406 hasConcept C2779113765 @default.
• W2002152406 hasConcept C2780827179 @default.
• W2002152406 hasConcept C2781114197 @default.
• W2002152406 hasConcept C543025807 @default.
• W2002152406 hasConcept C55493867 @default.
• W2002152406 hasConcept C71924100 @default.
• W2002152406 hasConcept C86803240 @default.
• W2002152406 hasConceptScore W2002152406C103796816 @default.
• W2002152406 hasConceptScore W2002152406C118487528 @default.
• W2002152406 hasConceptScore W2002152406C126322002 @default.
• W2002152406 hasConceptScore W2002152406C142724271 @default.
• W2002152406 hasConceptScore W2002152406C19038510 @default.
• W2002152406 hasConceptScore W2002152406C204787440 @default.
• W2002152406 hasConceptScore W2002152406C27081682 @default.

• next